August 23, 2025 – August 24, 2025
Pharmacy Laws and Rules Conference
(12hrs. CPE)

Home August 23, 2025 – August 24, 2025
Pharmacy Laws and Rules Conference
(12hrs. CPE)
Sale!

August 23, 2025 – August 24, 2025
Pharmacy Laws and Rules Conference
(12hrs. CPE)

Original price was: $250.00.Current price is: $225.00.

ACCREDITATION

iCARE Pharmacy Services, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is an ACPE application-based* and knowledge-based activity. Participants may receive up to 12 hours of CPE credit by attending sessions and successfully completing the continuing pharmacy education (CPE) activity evaluation.

iCARE Pharmacy Services, Inc. is approved by the Florida Board of Pharmacy as a provider of continuing pharmacy education.

DISCLOSURES

Speakers have no relevant conflict of interests nor financial relationships.  All persons in a position to control the content of this activity have declared that no conflict of interest exists for this activity.

TARGET AUDIENCE

Pharmacists and Pharmacy Technicians of all practice backgrounds.

CANCELLATION POLICY
Participants must submit cancellations in writing. Participants will receive a credit for a future CPE program.

ZOOM WEBINAR INFORMATION
Participants may join via any electronic device. Be sure to have downloaded the ZOOM software in advance to avoid any delays. You will be able to see the speakers and their presentations. You will be able to respond to speaker learning assessments via the CHAT Feature and ask questions via the Q&A Feature.

Required Computer Hardware/Software

Please ensure your computer system meets the following Zoom minimum requirements:

  • 32-bit or 64-bit processor
  • Internet Browser (MAC and/or Windows) – Internet Explorer, Google Chrome, Firefox, Safari
  • Broadband internet connection: cable, high-speed DSL and any other medium that is internet accessible. Connect to hard wired Ethernet, secondary monitor, webcam, microphone
  • Monitor Screen Resolution – Need high resolution at least 320×480
  • Audio system – Computer speakers or headphones, laptop integrated speakers or desktop speakers
  • Media Viewing Requirements – Microsoft PowerPoint, Adobe reader
Add to Wishlist
Categories: , Tag:

Description

Saturday, August 23, 2025

Pharmacy Legislative Update 2025                          

8:00-9:00am Consultant/General

Jonathan Hickman, PharmD, Medical Executive Director, Genentech

Upon completion of this activity, pharmacists will be able to: Discuss the recent changes of the 2025 Legislative Session and its effect on the profession of pharmacy; Describe the steps pharmacy must complete to maintain compliance with current Florida laws; Provide resources the profession may access to remain up to date with current Florida laws.

UAN: 0675-0000-25-022-L03-P

 

Upon completion of this activity, technicians will be able to: Discuss the recent changes of the 2025 Legislative Session and its effect on the profession of pharmacy; Describe the steps pharmacy must complete to maintain compliance with current Florida laws; Provide resources the profession may access to remain up to date with current Florida laws.

UAN: 0675-0000-25-022-L03-T

 

Sterile Compounding: The Road to Compliance                                           

9:00-11:00am Consultant/General

Gillian Staiko, RPh, CISCI, Regulatory Compliance Director, Hims and Hers

Upon completion of this activity, pharmacists will be able to: Describe the importance of USP; Discuss the requirements of USP 797 and 800; Identify the FDA Guidance Documents that apply to 503a pharmacies.
UAN: 0675-0000-25-023-L07-P

 

Upon completion of this activity, technicians will be able to: Describe the importance of USP; Discuss the requirements of USP 797 and 800; Identify the FDA Guidance Documents that apply to 503a pharmacies.

UAN: 0675-0000-25-023-L07-T

 

Anatomy of a Pharmacy Fraud Case              

11:15-12:45pm Consultant/General

Ronald Chapman II, Founder and Manager, Safe Harbor Group

Upon completion of this activity, pharmacists will be able to: Identify top compliance risks commonly faced by pharmacies and other healthcare entities; Evaluate how their current compliance practices align with regulatory expectations; Apply practical strategies to mitigate compliance risk and integrate a proactive compliance culture.

UAN: 0675-0000-25-024-L03-P

 

Upon completion of this activity, technicians will be able to: Identify top compliance risks commonly faced by pharmacies and other healthcare entities; Evaluate how their current compliance practices align with regulatory expectations; Apply practical strategies to mitigate compliance risk and integrate a proactive compliance culture.

UAN: 0675-0000-25-024-L03-T

 

Florida Board of Pharmacy 2024-2025 Legislation and Rule Update   

12:45-2:15pm Consultant/General

Chris Bierdlam, Of Counsel, Grossman Roopnarine & Bayó, LLC.

Upon completion of this activity, pharmacists will be able to:  Identify recent changes to the Florida statutes affecting the practice of pharmacy and the rule provisions being amended by the Board of Pharmacy to implement those changes; Explain how these new statutes and rules will impact the everyday practice of pharmacy in Florida including licensure implications, compounding, dispensing, recordkeeping, and patient counseling; Evaluate the implications that these changes will have on the everyday practice life of practicing pharmacists; Describe the updates related to pharmacy technician supervision and the current status of the Board’s proposed expansion of pharmacy technician supervision; Apply current legal requirements to real-world pharmacy scenarios to ensure compliance; Recognize the role of pharmacists in collaborative practice and test and treat settings and how they can enhance public health through policy engagement; Summarize anticipated future legislative trends and their potential impact on pharmacy practice.

UAN: 0675-0000-25-025-L03-P

 

Upon completion of this activity, technicians will be able to: Identify recent changes to the Florida statutes affecting the practice of pharmacy; Explain how these new statutes and rules will impact the everyday practice of pharmacy in Florida; Describe the updates related to pharmacy technician supervision and the current status of the Board’s proposed expansion of pharmacy technician supervision; Apply current legal requirements to real-world pharmacy scenarios to ensure compliance.

UAN: 0675-0000-25-025-L03-T

 

Sunday, April 24, 2025

CMS Medication Updates and Regulations in LTC Settings

8:00-9:30am Consultant/General

Lynn D’Avico, PharmD, CPH, Clinical Education Coordinator, Polaris Pharmacy

Upon completion of this activity, pharmacists will be able to: Update guidance/language for CMS regulatory changes; Discuss changes to F-tags and its effect on survey process; Discuss guidance changes to: Fentanyl Patch disposal, Antibiotic Stewardship requirements, CMS regulations on psychotropic medications, and guidance on Unnecessary Medications in LTC settings; Describe trauma and its effects on residents and staff.

UAN: 0675-0000-25-027-L03-P

 

Upon completion of this activity, technicians will be able to: Review language for CMS regulatory changes; Discuss changes to F-tags and its effect on survey process; Discuss guidance changes to: Fentanyl Patch disposal, Antibiotic Stewardship requirements, CMS regulations on psychotropic medications, and guidance on Unnecessary Medications in LTC settings; Describe trauma and its effects on residents and staff.

UAN: 0675-0000-25-027-L03-T

 

From COVID to AI in Telepharmacy                                                      

9:30-11:00am Consultant/General

Christopher B. Sullivan, PhD, President, Image Research LLC

Upon completion of this activity, pharmacists will be able to: Explain the basic applications of telepharmacy technology as they exist today; Recognize the innovations in telepharmacy services due to the COVID-19 pandemic; Describe the background of AI as it developed out of earlier systems such as IBM’s Watson, Google’s search engine and Apple’s SIRI algorithms; Identify the difference between Traditional AI, which can learn from data and make predictions based on the date, and Generative AI, which can create new formulations from existing data; Discuss future telepharmacy opportunities and challenges created by AI.

UAN:0675-0000-25-028-L04-P

Upon completion of this activity, technicians will be able to: Explain the basic applications of telepharmacy technology as they exist today; Recognize the innovations in telepharmacy services due to the COVID-19 pandemic; Describe the background of AI as it developed out of earlier systems such as IBM’s Watson, Google’s search engine and Apple’s SIRI algorithms; Identify the difference between Traditional AI, which can learn from data and make predictions based on the date, and Generative AI, which can create new formulations from existing data; Discuss future telepharmacy opportunities and challenges created by AI.

UAN: 0675-0000-25-028-L04-T

 

DSCSA: “Take Two” for Title II

11:15-12:45pm Consultant/General

Heather Fuller, PharmD, M.B.A., M.S., AdventHealth, Corporate Pharmacy Procurement Manager,

Upon completion of this activity, pharmacists will be able to: Discuss the history of DSCSA and where we are now; Develop a solid understanding of the DSCSA requirements for Dispensers; Review case scenarios and ways to operationalize the requirements.

UAN: 0675-0000-25-029-L03-P

 

Upon completion of this activity, technicians will be able to: Discuss the history of DSCSA and where we are now; Develop a solid understanding of the DSCSA requirements for Dispensers; Review case scenarios and ways to operationalize the requirements.

UAN: 0675-0000-25-029-L03-T

 

Florida Pharmacy Law & the Disciplinary Process                   

12:45-2:15pm Consultant/General

Edwin Bayo, Founding Partner, Grossman, Roopnarine & Bayó, LLC.

Upon completion of this activity, pharmacists will be able to: Describe the life cycle of a Department of Health/Board of Pharmacy investigation from complaint intake through probable cause review, administrative processes, board action, and remedies; Compare the due process rights of pharmacists and permit holders at each stage of the disciplinary process, including notice requirements, access to the investigative file, and available hearing options; Identify the statutory and rule-based grounds for discipline under Chapters 456, 465, 499 & 893, Florida Statutes, and Rule Chapter 64B16, F.A.C., with emphasis on misfills, inspection deficiencies, impairment, and criminal convictions; Formulate proactive compliance strategies—including record-keeping, staff training, and self-reporting—that reduce the risk of disciplinary action and support mitigation if violations occur; Explain the role and obligations of key pharmacy leaders (Prescription Department Manager/PIC and designated representatives) in maintaining permit compliance and responding to DOH inquiries.

UAN: 0675-0000-25-030-L03-P

 

Upon completion of this activity, technicians will be able to: Describe the life cycle of a Department of Health/Board of Pharmacy investigation from complaint intake through probable cause review, administrative processes, board action, and remedies; Identify the due process rights at each stage of the disciplinary process; Explain the role and obligations of key pharmacy leaders (Prescription Department Manager/PIC and designated representatives) in maintaining permit compliance and responding to DOH inquiries.

UAN: 0675-0000-25-030-L03-T

Related products